Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618663.RAijR9o3lyrM47Q6Uk_izjMmBcdj6WSIn5F1HmgrEUPJg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618663.RAijR9o3lyrM47Q6Uk_izjMmBcdj6WSIn5F1HmgrEUPJg130_assertion type Assertion NP618663.RAijR9o3lyrM47Q6Uk_izjMmBcdj6WSIn5F1HmgrEUPJg130_head.
- NP618663.RAijR9o3lyrM47Q6Uk_izjMmBcdj6WSIn5F1HmgrEUPJg130_assertion description "[Significant use of selective cyclooxygenase-2 (COX-2) blocking agents prescribed for the treatment of arthritis during 1999 to 2005 facilitates epidemiologic investigations to illuminate their chemopreventive effects against human cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618663.RAijR9o3lyrM47Q6Uk_izjMmBcdj6WSIn5F1HmgrEUPJg130_provenance.
- NP618663.RAijR9o3lyrM47Q6Uk_izjMmBcdj6WSIn5F1HmgrEUPJg130_assertion evidence source_evidence_literature NP618663.RAijR9o3lyrM47Q6Uk_izjMmBcdj6WSIn5F1HmgrEUPJg130_provenance.
- NP618663.RAijR9o3lyrM47Q6Uk_izjMmBcdj6WSIn5F1HmgrEUPJg130_assertion SIO_000772 17612052 NP618663.RAijR9o3lyrM47Q6Uk_izjMmBcdj6WSIn5F1HmgrEUPJg130_provenance.
- NP618663.RAijR9o3lyrM47Q6Uk_izjMmBcdj6WSIn5F1HmgrEUPJg130_assertion wasDerivedFrom befree-2016 NP618663.RAijR9o3lyrM47Q6Uk_izjMmBcdj6WSIn5F1HmgrEUPJg130_provenance.
- NP618663.RAijR9o3lyrM47Q6Uk_izjMmBcdj6WSIn5F1HmgrEUPJg130_assertion wasGeneratedBy ECO_0000203 NP618663.RAijR9o3lyrM47Q6Uk_izjMmBcdj6WSIn5F1HmgrEUPJg130_provenance.